selective mutism - speech deficit
Conditions
Interventions
None listed
Sponsors
Universitair Medisch Centrum Utrecht
Eligibility
Age
2 Years to 99 Years
Inclusion criteria
Inclusion criteria: clinical DSM-IV diagnosis of selective mutism
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main objective of this study is to assess long-term outcome of subjects once referred to our department with SM. We expect that at follow up (min 2 years after treatment) the subjects will not fulfil criteria for SM anymore, but it might be expected based on the literature, that a subgroup still has symptoms of psychiatric disorders and/or neuropsychological deficits (such as reduced cognitive flexibility or attention problems). We will assess present functioning and possible remaining psychopathology in our sample and investigate whether different subgroups (children with bilingual backgrounds, children with or without language deficits) have different outcome. | — |
Secondary
| Measure | Time frame |
|---|---|
| We are interested in the experiences of the patients and their parents at hindsight and hope that we learn from their experience to improve our care. We aim to examine whether demographic factors, family factors or behavioural characterics correlate with severity of impairment and predict adult symptomatic outcome. Moreover we expect individuals once referred for treatment of SM to show (neuro)psychological or language deficits that might have played a role in the development of their fear to speak. Also, we aim to examine whether children with selective mutism are more likely to have first or second degree family members with PDD or PDD-like characteristics and whether PDD or PDD-like characteristics (such as (cognitive) rigidity) will be found more often at follow up in the individuals themselves. We expect to find an overlap between the conditions SM and PDD in a subgroup of our sample and we expect significant differences between these groups in symptomatology, treatment effect or long-term outcome. | — |
Countries
Netherlands
Outcome results
None listed